Engaging in unprotected sex with multiple partners increases the risk of contracting multiple strains of HIV. Once inside a host, these strains can recombine into a new variant of the virus, researchers said.
One such recombinant variant observed in patients in Cuba appears to be much more aggressive than other known forms of HIV, researchers said.
Before it can enter human cells, HIV must first anchor itself to them. The virus does this via anchor points, or co-receptors, which are proteins on the cell membrane.
This co-receptor switch coincides with a faster progression to AIDS.
Researchers at KU Leuven's Laboratory for Clinical and Epidemiological Virology in Belgium have described a recombinant form of HIV observed in patients in Cuba that makes this transition much faster.
The virus targets the anchor point CXCR4 early after infection, shortening drastically the healthy phase and triggering rapid progression to AIDS.
Professor Anne-Mieke Vandamme and colleagues studied the blood of 73 recently-infected patients - 52 at AIDS diagnosis and 21 without AIDS - and compared results with blood from 22 patients who had progressed to AIDS after a normal healthy period with HIV.
This molecule is part of the natural immune response and acts through binding to CCR5, to which most forms of HIV have to bind before entering the cell.
The high concentration of RANTES suggests that most of the CCR5 proteins were no longer available as anchor points for HIV. This may have caused the HIV recombinant to bypass that anchor point and go straight to anchor point CXCR4.
The observation that all study patients who were infected with the recombinant HIV variant went on to develop AIDS within three years of infection supports this theory, researchers said.
One of these fragments contains a protease (from subtype D), which acts very efficiently. Protease is an enzyme that cleaves the proteins that are used in new virus particles.
This protease is very 'fit' - it enables the virus to replicate in greater numbers hence facilitating the transition to CXCR4 anchoring, researchers said.
The study is published in the journal EBioMedicine.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
